A Study to Evaluate the Effect of Funk It Cycle Bites on PMS
An Open-Label, Single-Group Study to Evaluate the Effect of Funk It Cycle Bites on PMS
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a virtual, open-label, single-group study that will last 4 menstrual cycles. All participants will complete a questionnaire at the end of their first period after enrolling (baseline/non-intervention cycle 1), then proceed to take the product daily and complete questionnaires at the end of their next 3 periods (intervention cycles 1, 2, and 3). The study will involve 30 female participants with regular menstrual cycles who experience PMS. Questionnaires will be used to monitor menstrual pain/cramps, energy levels, mood, and hormonal acne experienced before and during the menstrual cycle. Likert scale responses will be statistically compared from baseline to each check-in. Participant responses on product feedback will be presented as % scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 2, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedFebruary 29, 2024
February 1, 2024
4 months
June 2, 2023
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Change in symptoms of premenstrual syndrome. [Time Frame: Baseline to Month 4]
Survey-based assessment of symptoms using the Premenstrual Symptoms Screening Tool (PSST). Responses will be gathered using a 4-point Likert scale.
4 months
Changes in acne. [Time Frame: Baseline to Month 4]
Survey-based assessment of acne using the Acne Quality of Life (Acne-QOL) scale. Responses will be gathered using a 5-point Likert scale.
4 months
Changes in pain levels, including menstrual cramps. [Time Frame: Baseline to Month 4]
Survey-based assessment of acne using the Numerical Pain Rating Scale, a 0-10 point rating scale.
4 months
Changes in mood stability. [Time Frame: Baseline to Month 4]
Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.
4 months
Changes in energy levels. [Time Frame: Baseline to Month 4]
Survey-based assessment using study-specific questionnaires. Responses will be gathered using a 5-point Likert scale.
4 months
Secondary Outcomes (1)
Participant enjoyment of the product.
4 months
Study Arms (1)
Cycle Bites
EXPERIMENTALParticipants will consume 1 Cycle Bite per day.
Interventions
The intervention product contains: Organic Pumpkin Seed Butter, Prebiotic Agave Inulin, Organic Flax Seed, Organic Oat Flour, Organic Ginger, Quinoa Sprouts, Crispy Red Rice, Organic Cacao Nibs, Sunflower Seed Butter, Organic Reishi Mushroom, Organic Amaranth Seeds, Dates, Organic Button Mushroom, Acai Berry, Amla Fruit, Goji Berry, Pomegranate, Cranberry, Acerola (Cherry Juice), Rosemary Extract, Vitamin E (Mixed Tocopherols), Organic Vanilla Extract, Sea Salt, Cinnamon, Naturally Sourced Potassium Sorbate.
Eligibility Criteria
You may qualify if:
- Female aged 18-40
- Have a regular menstrual cycle (every 21-35 days).
- Suffer from mild to moderate menstrual pain.
- May experience mood swings and/or hormonal acne related to the menstrual cycle.
- Otherwise generally healthy.
- Willing to consume the test product with a ginger flavor.
- Willing to refrain from taking any other supplements or prescription medications that may target the menstrual cycle or premenstrual syndrome (PMS) symptoms throughout the study period.
- Willing and able to adhere to the study protocol, including taking supplements at the required times and completing questionnaires via the technology portal.
- Able to communicate in English.
- Participants must provide written informed consent (ICF).
You may not qualify if:
- Any unstable or uncontrolled medical or psychiatric illness.
- Any uncontrolled chronic disease or condition that would prevent full participation in the study protocol.
- A history of polycystic ovary syndrome (PCOS), endometriosis, premenstrual dysphoric disorder (PMDD), or undiagnosed vaginal bleeding.
- Are taking hormonal contraception or exogenous sex hormones (estrogen, testosterone, progesterone), or have taken hormonal contraception or exogenous hormones in the past 6 months.
- Are taking any prescription medication or supplements that target the menstrual cycle or PMS symptoms.
- Are pregnant, breastfeeding, trying to become pregnant, or have been pregnant in the past 12 months.
- Have any known severe allergic reactions, or any allergies of any severity to any of the test product's ingredients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Funk It Wellnesslead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Santa Monica, California, 90404, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2023
First Posted
June 12, 2023
Study Start
May 1, 2023
Primary Completion
September 1, 2023
Study Completion
October 1, 2023
Last Updated
February 29, 2024
Record last verified: 2024-02